Rehovot-based Foamix Ltd. announced that two Institutional Review Boards reviewed and cleared its Phase I/II clinical study for Minocycline Foam in Acne patients. The Phase II multicentre clinical trial is designed to assess the safety and clinical efficacy of Foamix’s topical Minocycline Foam in patients with moderate to severe acne....
Read more